Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Opinion in Drug Discovery & Development
|
September 19, 2001
The development of pharmacogenomic models to predict drug response
G I Adam
Placenta
|
January 1, 1996
Genomic imprinting and mammalian development
G C Franklin, G I Adam, R Ohlsson
Gene
|
October 31, 1996
Cell-type-specific modulation of PDGF-B regulatory elements via viral enhancer competition: a caveat for the use of reference plasmids in transient transfection assays
G I Adam, S J Miller, E Ullerås, et al.
Development (Cambridge, England)
|
March 1, 1996
Allele-specific in situ hybridization (ASISH) analysis: a novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development
G I Adam, H Cui, S J Miller, et al.
Pharmacogenomics
|
March 22, 2001
Pharmacogenomics to predict drug response
G I Adam, R Reneland, M Andersson, et al.
The EMBO Journal
|
June 1, 1991
Expression of the human PDGF-B gene is regulated by both positively and negatively acting cell type-specific regulatory elements located in the first intron
G C Franklin, M Donovan, G I Adam, et al.
Development Genes and Evolution
|
February 18, 1999
Random monoallelic expression of the imprinted IGF2 and H19 genes in the absence of discriminative parental marks
R Ohlsson, F Flam, R Fisher, et al.
Oncogene
|
November 2, 1995
An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer
G C Franklin, G I Adam, S J Miller, et al.
Experimental Cell Research
|
October 20, 2001
Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer
E Ullerås, S J Miller, G I Adam, et al.
Growth Factors (Chur, Switzerland)
|
February 5, 1999
A novel type of regulatory element is required for promoter-specific activity of the PDGF-B intronic enhancer region
S J Miller, E Ullerås, C L Moncrieff, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Opinion in Drug Discovery & Development
|
September 19, 2001
The development of pharmacogenomic models to predict drug response
G I Adam
Placenta
|
January 1, 1996
Genomic imprinting and mammalian development
G C Franklin, G I Adam, R Ohlsson
Gene
|
October 31, 1996
Cell-type-specific modulation of PDGF-B regulatory elements via viral enhancer competition: a caveat for the use of reference plasmids in transient transfection assays
G I Adam, S J Miller, E Ullerås, et al.
Development (Cambridge, England)
|
March 1, 1996
Allele-specific in situ hybridization (ASISH) analysis: a novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development
G I Adam, H Cui, S J Miller, et al.
Pharmacogenomics
|
March 22, 2001
Pharmacogenomics to predict drug response
G I Adam, R Reneland, M Andersson, et al.
The EMBO Journal
|
June 1, 1991
Expression of the human PDGF-B gene is regulated by both positively and negatively acting cell type-specific regulatory elements located in the first intron
G C Franklin, M Donovan, G I Adam, et al.
Development Genes and Evolution
|
February 18, 1999
Random monoallelic expression of the imprinted IGF2 and H19 genes in the absence of discriminative parental marks
R Ohlsson, F Flam, R Fisher, et al.
Oncogene
|
November 2, 1995
An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer
G C Franklin, G I Adam, S J Miller, et al.
Experimental Cell Research
|
October 20, 2001
Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer
E Ullerås, S J Miller, G I Adam, et al.
Growth Factors (Chur, Switzerland)
|
February 5, 1999
A novel type of regulatory element is required for promoter-specific activity of the PDGF-B intronic enhancer region
S J Miller, E Ullerås, C L Moncrieff, et al.
Page
of 1